Page last updated: 2024-11-03

propantheline and Experimental Neoplasms

propantheline has been researched along with Experimental Neoplasms in 2 studies

Propantheline: A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking.

Research Excerpts

ExcerptRelevanceReference
" Pharmacokinetic experiments show oral bioavailability through gastric absorption."1.48Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization. ( Cescon, DW; Hansen, MD; Hoj, JP; Siddiqui-Jain, A, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Siddiqui-Jain, A1
Hoj, JP1
Cescon, DW1
Hansen, MD1
Kowalewski, K1
Kasper, T1

Other Studies

2 other studies available for propantheline and Experimental Neoplasms

ArticleYear
Pharmacology and in vivo efficacy of pyridine-pyrimidine amides that inhibit microtubule polymerization.
    Bioorganic & medicinal chemistry letters, 2018, 03-01, Volume: 28, Issue:5

    Topics: Amides; Animals; Cell Line, Tumor; Cell Proliferation; Dogs; Dose-Response Relationship, Drug; Human

2018
Achlorhydria, gastric mucosal atrophy and gastric neoplastic lesions in rats, mice and hamsters treated with an anticholinergic drug, propantheline bromide, and a carcinogen, 20-methylcholanthrene.
    Canadian journal of surgery. Journal canadien de chirurgie, 1967, Volume: 10, Issue:1

    Topics: Achlorhydria; Animals; Atrophy; Cricetinae; Gastric Mucosa; In Vitro Techniques; Methylcholanthrene;

1967